Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Raw Materials: 2023-2024

Historic Raw Materials for Krystal Biotech (KRYS) over the last 2 years, with Dec 2024 value amounting to $13.6 million.

  • Krystal Biotech's Raw Materials rose 62.10% to $14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year increase of 62.10%. This contributed to the annual value of $13.6 million for FY2024, which is 332.44% up from last year.
  • According to the latest figures from FY2024, Krystal Biotech's Raw Materials is $13.6 million, which was up 332.44% from $3.2 million recorded in FY2023.
  • Over the past 5 years, Krystal Biotech's Raw Materials peaked at $13.6 million during FY2024, and registered a low of $3.2 million during FY2023.
  • Its 2-year average for Raw Materials is $8.4 million, with a median of $8.4 million in 2023.
  • Data for Krystal Biotech's Raw Materials shows a peak YoY surged of 332.44% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Krystal Biotech's Raw Materials stood at $3.2 million in 2023, then skyrocketed by 332.44% to $13.6 million in 2024.